Literature DB >> 24532051

Pre-eclampsia and cardiovascular disease.

Christina W Chen1, Iris Z Jaffe, S Ananth Karumanchi.   

Abstract

Heart disease is the leading cause of death in women in all countries. A history of pre-eclampsia, one of the most deadly hypertensive complications of pregnancy, increases cardiovascular risk by two to four times, which is comparable with the risk induced by smoking. Substantial epidemiological data reveal that pregnancy-related hypertensive complications are associated with a predisposition to chronic hypertension, premature heart attacks, strokes, and renal complications. In this review, we summarize clinical studies that demonstrate this relationship and also discuss the pathogenesis of these long-term complications of pre-eclampsia. Future studies should focus on strategies to prevent the progression of cardiovascular disease in women exposed to pre-eclampsia, thereby improving long-term cardiovascular health in women.

Entities:  

Keywords:  Angiogenesis; Cardiovascular disease; Chronic kidney disease; Hypertension; Pre-eclampsia; Proteinuria; Stroke; sFlt1

Mesh:

Year:  2014        PMID: 24532051      PMCID: PMC3941598          DOI: 10.1093/cvr/cvu018

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  60 in total

1.  Pregnancy: a screening test for later life cardiovascular disease.

Authors:  James M Roberts; Carl A Hubel
Journal:  Womens Health Issues       Date:  2010-09

2.  Long-term prognosis of hypertension in pregnancy.

Authors:  R Marín; M Gorostidi; C G Portal; M Sánchez; E Sánchez; J Alvarez
Journal:  Hypertens Pregnancy       Date:  2000       Impact factor: 2.108

3.  The remote prognosis of eclamptic women. Sixth periodic report.

Authors:  L C Chesley; J E Annitto; R A Cosgrove
Journal:  Am J Obstet Gynecol       Date:  1976-03-01       Impact factor: 8.661

4.  Microalbuminuria after pregnancy complicated by pre-eclampsia.

Authors:  J Bar; B Kaplan; C Wittenberg; A Erman; G Boner; Z Ben-Rafael; M Hod
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

5.  Dyslipoproteinaemia in postmenopausal women with a history of eclampsia.

Authors:  C A Hubel; S Snaedal; R B Ness; L A Weissfeld; R T Geirsson; J M Roberts; R Arngrímsson
Journal:  BJOG       Date:  2000-06       Impact factor: 6.531

6.  Long-term mortality after preeclampsia.

Authors:  Edmund F Funai; Yechiel Friedlander; Ora Paltiel; Efrat Tiram; Xiaonan Xue; Lisa Deutsch; Susan Harlap
Journal:  Epidemiology       Date:  2005-03       Impact factor: 4.822

7.  Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk.

Authors:  Yoav Yinon; John C P Kingdom; Ayodele Odutayo; Rahim Moineddin; Sascha Drewlo; Vesta Lai; David Z I Cherney; Michelle A Hladunewich
Journal:  Circulation       Date:  2010-10-18       Impact factor: 29.690

8.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

9.  Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.

Authors:  Myles Wolf; Carl A Hubel; Chun Lam; Marybeth Sampson; Jeffrey L Ecker; Roberta B Ness; Augustine Rajakumar; Ashi Daftary; Alia S M Shakir; Ellen W Seely; James M Roberts; Vikas P Sukhatme; S Ananth Karumanchi; Ravi Thadhani
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

10.  Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors.

Authors:  Elisabeth B Magnussen; Lars J Vatten; George Davey Smith; Pål R Romundstad
Journal:  Obstet Gynecol       Date:  2009-11       Impact factor: 7.661

View more
  62 in total

Review 1.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

2.  Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia.

Authors:  Suzanne D Burke; Zsuzsanna K Zsengellér; Eliyahu V Khankin; Agnes S Lo; Augustine Rajakumar; Jennifer J DuPont; Amy McCurley; Mary E Moss; Dongsheng Zhang; Christopher D Clark; Alice Wang; Ellen W Seely; Peter M Kang; Isaac E Stillman; Iris Z Jaffe; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

Review 3.  Sex differences in mechanisms of arterial stiffness.

Authors:  Jennifer J DuPont; Rachel M Kenney; Ayan R Patel; Iris Z Jaffe
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

4.  Focus on pregnancy-mediated heart and vascular disease.

Authors:  Denise Hilfiker-Kleiner; Zolt Arany
Journal:  Cardiovasc Res       Date:  2014-02-11       Impact factor: 10.787

5.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

Review 6.  National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness: Building on the Current Scientific Evidence.

Authors:  Young S Oh; Lawrence J Appel; Zorina S Galis; David A Hafler; Jiang He; Amanda L Hernandez; Bina Joe; S Ananth Karumanchi; Christine Maric-Bilkan; David Mattson; Nehal N Mehta; Gwendolyn Randolph; Michael Ryan; Kathryn Sandberg; Jens Titze; Eser Tolunay; Glenn M Toney; David G Harrison
Journal:  Hypertension       Date:  2016-06-20       Impact factor: 10.190

7.  Pre-eclampsia and risk of subsequent hypertension: in an American Indian population.

Authors:  Lyle G Best; Laramie Lunday; Elisha Webster; Gilbert R Falcon; James R Beal
Journal:  Hypertens Pregnancy       Date:  2016-12-21       Impact factor: 2.108

8.  Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia.

Authors:  Jennifer L Sones; Audrey A Merriam; Angelina Seffens; Dex-Ann Brown-Grant; Scott D Butler; Anna M Zhao; Xinjing Xu; Carrie J Shawber; Jennifer K Grenier; Nataki C Douglas
Journal:  FASEB J       Date:  2018-01-08       Impact factor: 5.191

Review 9.  Current Updates on Pre-eclampsia: Maternal and Foetal Cardiovascular Diseases Predilection, Science or Myth? : Future cardiovascular disease risks in mother and child following pre-eclampsia.

Authors:  Samson A Odukoya; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2021-03-10       Impact factor: 5.369

Review 10.  Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease.

Authors:  Xin Zhou; Jian-Min Niu; Wen-Jie Ji; Zhuoli Zhang; Peizhong P Wang; Xue-Feng B Ling; Yu-Ming Li
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.